Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
USE OF LONG-CHAIN NON-CODING RNA AS PROSTATIC CANCER MOLECULE MARKER
Document Type and Number:
WIPO Patent Application WO/2018/219264
Kind Code:
A1
Abstract:
A long-chain non-coding RNA marker lncLOX5-1 for early diagnosis and prognosis of prostatic cancer and use thereof. Said lncLOX5-1 has the characteristics of high accuracy, high specificity, and high sensitivity, being able to be used for early diagnosis and prognosis of prostatic cancer.

More Like This:
WO/2019/010274RNAi AGENTS FOR INHIBITING EXPRESSION OF ALPHA-ENaC AND METHODS OF USE
WO/2017/197038LENTIVIRAL DELIVERY OF CRISPR/CAS CONSTRUCTS THAT CLEAVE GENES ESSENTIAL FOR HIV-1 INFECTION AND REPLICATION
JP2022541387Methods and compositions for proximity ligation
Inventors:
SUN YINGHAO (CN)
REN SHANCHENG (CN)
SHI XIAOLEI (CN)
LIU FEI (CN)
Application Number:
PCT/CN2018/088809
Publication Date:
December 06, 2018
Filing Date:
May 29, 2018
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
CHANGHAI HOSPITAL SHANGHAI (CN)
International Classes:
C12N15/11; C12N15/113; C12Q1/68
Domestic Patent References:
WO2014077354A12014-05-22
Foreign References:
CN106967719A2017-07-21
CN104498495A2015-04-08
CN105154448A2015-12-16
CN106148561A2016-11-23
CN105316341A2016-02-10
CN103797120A2014-05-14
US9410206B22016-08-09
Attorney, Agent or Firm:
MSJ LAW OFFICE (CN)
Download PDF:
View/Download PDF      PDF Help



 
Previous Patent: STEPLESS GRAPHENE FILTER CHOKE AND MANUFACTURING METHOD THEREOF

Next Patent: BEARING DETECTING DEVICE AND METHOD